|
24 July, 2024
|
ICON announces results of Annual General Meeting and changes to the Board of Directors
|
|
|
10 July, 2024
|
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
|
|
|
01 July, 2024
|
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
|
|
|
04 June, 2024
|
ICON plc to Present at the Jefferies Global Healthcare Conference
|
|
|
30 May, 2024
|
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
|
|
|
20 May, 2024
|
ICON plc to hold Investor Day Meeting on May 30, 2024
|
|
|
09 May, 2024
|
ICON releases its ICON Cares 2023 Report
|
|
|
30 April, 2024
|
ICON Announces Pricing of USD 2 Billion Notes
|
|
|
24 April, 2024
|
ICON Reports First Quarter 2024 Results
|
|
|
03 April, 2024
|
ICON Announces CFO Transition
|
|
|
25 March, 2024
|
ICON plc Schedules First Quarter 2024 Earnings Conference Call
|
|
|
26 February, 2024
|
ICON plc to Present at Upcoming Investor Conferences
|
|
|
21 February, 2024
|
ICON Reports Fourth Quarter and Full Year 2023 Results
|
|
|
30 January, 2024
|
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
|
|
|
24 January, 2024
|
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
|
|
|
09 January, 2024
|
ICON Issues Financial Guidance for Full Year 2024
|
|
|
08 January, 2024
|
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
|
|
|
04 January, 2024
|
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
|
18 December, 2023
|
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
|
|
|
07 December, 2023
|
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
|
|
